The British Columbia Centre for Excellence in HIV/AIDS at St. Paul’s Hospital to launch powerful Big Data technology with the help of PHEMI Health Systems and SAP AG

VANCOUVER, Canada, 25-2-2014 — /EuropaWire/ — The British Columbia Centre for Excellence in HIV /AIDS at St. Paul’s Hospital is pioneering new technology from PHEMI Health Systems and SAP AG (NYSE: SAP) to accelerate the treatment and improve the outcome for patients diagnosed with HIV/AIDS. The Centre intends to roll out powerful Big Data technology in a pilot project to deliver personalized medicine based on the genetic signature of the virus that infects each patient.

“We’re changing the face of treatment for HIV and AIDS,” said Dr. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS. “This technology will be invaluable to the lives of our patients. We will be able to quickly treat patients by delivering personalized medicine based on their unique strain of the virus. This will help us save time and money while also significantly decreasing the number of new HIV and AIDS cases. For the first time, we will have access to vast amounts of information and get answers immediately thanks to technology from PHEMI and SAP.”

The Center for Excellence aims to implement PHEMI Central’s healthcare data warehouse and the SAP HANA® platform. PHEMI Central shall be used to store, archive and govern the research and clinical information in a healthcare-specific data warehouse that is embedded with ‘Privacy by Design‘ capabilities. The solutions from PHEMI and SAP are envisioned to be used together, delivering advanced, personalized and private medicine information.

“Over 70 percent of healthcare information is unstructured and difficult to mine for relevant insight using traditional methods,” said Dr. Paul Terry, CEO of PHEMI Health Systems. “What we intend to offer healthcare professionals, essentially, is the ability to turn physician letters and lab results into searchable information, thereby helping to unlock vast amounts of new information for clinicians, analysts and researchers.”

“Our cooperation with PHEMI and the work we do with the Centre for Excellence is a great proof point highlighting that forward-thinking Canadian companies, taking bold actions, can lead the world in their industries,” said Bob Elliott, managing director, SAP Canada. “Doctors and researchers are envisioned to have a much faster way of treating patients. Working together, we plan on lowering healthcare costs by speeding up treatment plans, improving patient care and addressing chronic disease as a whole.”

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada’s largest HIV/AIDS research, treatment and education facility and is internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases.

For more information, visit the SAP Newsroom.

About SAP
As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 253,500 customers to operate profitably, adapt continuously, and grow sustainably. For more information, visit www.sap.com.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “should” and “will” and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP’s future financial results are discussed more fully in SAP’s filings with the U.S. Securities and Exchange Commission (“SEC”), including SAP’s most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

©2014 SAP AG. All rights reserved.
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP AG in Germany and other countries. Please see http://www.sap.com/corporate-en/legal/copyright/index.epx#trademark for additional trademark information and notices.

Note to Editors:
To preview and download broadcast-standard stock footage and press photos digitally, please visit www.sap.com/photos. On this platform, you can find high resolution material for your media channels. To view video stories on diverse topics, visit www.sap-tv.com. From this site, you can embed videos into your own Web pages, share video via email links, and subscribe to RSS feeds from SAP TV.

Follow SAP on Twitter at @sapnews.

For customers interested in learning more about SAP products:
Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:
Mat Small, +1 (510) 684-3552, m.small@sap.com, PST
Carole Beatty, SAP Canada, +1 (416) 564-7418, carole.beatty@sap.com, EST
SAP Press Office, +49 (6227) 7-46315, CET; +1 (610) 661-3200, EDT; press@sap.com